Neuer Masterstudiengang: Multiple Sklerose Management
Publikation: Beitrag in Fachzeitschrift › Forschungsartikel › Beigetragen › Begutachtung
Beitragende
Abstract
The new study program “Multiple Sclerosis Management” is aimed at physicians, therapists, nurses, scientists, pharmacists, psychologists and biologists who want to specialize in the field of multiple sclerosis (MS). After successful accreditation in 2019, the first students have been in the master’s program offered by Dresden International University (DIU) since 2020. Over a period of four semesters, it can be completed part-time and largely digitally. The master’s program is divided into six modules focusing on basics, clinical and diagnostic aspects, MS studies and statistics, disease-modifying and symptomatic therapy, disease monitoring and documentation. The teaching includes theoretical parts and numerous practical units. A further goal is to derive therapeutic intervention plans and problem-solving strategies from scientific publications and clinical studies, to develop them further and to apply them in patient care. The lecturers come from Germany, Austria and Switzerland and are predominantly professors. The German Multiple Sclerosis Society is the patron of the course. This article presents the study program in detail.
Details
Originalsprache | Deutsch |
---|---|
Seiten (von - bis) | 383-391 |
Seitenumfang | 9 |
Fachzeitschrift | Wiener Medizinische Wochenschrift |
Jahrgang | 172 |
Ausgabenummer | 15-16 |
Publikationsstatus | Veröffentlicht - Nov. 2022 |
Peer-Review-Status | Ja |
Externe IDs
Scopus | 85124089329 |
---|---|
ORCID | /0000-0003-0097-8589/work/146644025 |
PubMed | 35107651 |
Mendeley | 13c613c4-7337-3514-a0f4-d9f98f5f0db1 |